Thermography not a replacement for mammography
The Food and Drug Administration (FDA) today released a consumer warning that thermography should not be used in place of mammography for breast cancer screening or diagnosis.
The FDA says mammography- an X-ray of the breast-is still the most effective way of detecting breast cancer in its earliest stages. The wanring does not mention digital mammogrpahy or other modalities.
While thermography is cleared by FDA for use as an adjunct, or additional tool, it should not be used by itself to screen for, or diagnose, breast cancer, the agency clarifies.
Learn more about the FDA's concerns about the use of thermography as a screening tool at
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm257499.htm
Mammography and Breast MRI: Is it Time to Evaluate Strategies as Opposed to Modalities?
July 5th 2024The combination of mammography with breast MRI within 90 days had a 96.2 percent sensitivity in comparison to 48.1 percent for mammography and 79.7 percent for breast MRI performed within 91 to 270 days after index mammography, according to newly published research.
ACR Collaborative Model Leads to 35 Percent Improvement with Mammography Positioning Criteria
July 1st 2024Noting significant variation with facilities for achieving passing criteria for mammography positioning, researchers found that structured interventions, ranging from weekly auditing of images taken by technologists to mechanisms for feedback from radiologists to technologists, led to significant improvements in a multicenter study.